TPTW yields 2000000.00% · PFE yields 6.13%● Live data
📍 TPTW pulled ahead of the other in Year 1
Combined, TPTW + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TPTW + PFE for your $10,000?
TPT Global Tech, Inc. operates as a media content hub for domestic and international syndication technology/telecommunications companies worldwide. It also provides technology solutions for businesses. The company offers software as a service (SaaS), technology platform as a service (PAAS), cloud-based unified communication as a service (UCaaS), and carrier-grade performance and support services for businesses over its private IP MPLS fiber and wireless network. Its cloud-based UCaaS services allow businesses to access voice, data, media, and collaboration in technology markets. In addition, the company distributes pre-paid cellphone services, mobile phones, cellphone accessories, and global roaming cellphones for nationwide mobile virtual network operators and independent sales organization. Additionally, it offers phone, Internet, fiber optic, wireless, hosted PBX, Wi-Fi, Wi-Max, engineering, cabling, wiring, and cloud services; hosted firewall and managed MPLS service technologies; and enterprise-class integrated solutions for manufacturers, retailers, and distributors. Further, the company provides cloud unified businesses services that delivers global TV broadcast and social media platform utilizing a mobile app technology on its proprietary content delivery network; and creates original live action and animated content productions for television, theatrical, home entertainment, and new media markets, as well as operates as an Internet service provider. Additionally, it develops point-of-care diagnostics or testing products, including SANIQuik, a decontamination and sanitizing unit and QuikLAB mobile laboratories. The company was formerly known as Ally Pharma US, Inc. and changed its name to TPT Global Tech, Inc. in December 2014. TPT Global Tech, Inc. is headquartered in San Diego, California.
Full TPTW Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.